🔴 BioLineRx is trading 9.02% down in after-hours trading with no new company-specific catalyst identified

BioLineRx is trading 9.02% down at $2.32 after-hours on September 9, 2026, versus the regular-session close of $2.55; no major company announcement, earnings release, or regulatory filing dated September 9 was identified.

• The latest investor-relations update was published September 3.
• The recent $3.75 million financing and warrant overhang remain relevant background, but available evidence does not establish them as the cause of this after-hours decline.